Chronic breathlessness is very distressing and often prevents a good night’s sleep. Now, new research at Flinders University is taking a detailed look at the sleep […]
More than 20,000 Australian patients a year will benefit from the listing of a capsule to relieve chronic breathlessness. Mayne Pharma’s Kapanol, a low-dose, sustained release […]
More than 70,000 Australians who suffer from chronic breathlessness will have access to medication to help manage this debilitating symptom. In a world first, Mayne Pharma […]
On top of worrying about treatments and side effects, many people with cancer also worry about the cost of their care. In a new study, Australian […]
A national medication study is aiming to help thousands of Australians who struggle every day with shortness of breath.
Four Flinders medical research leaders have been honoured with fellowships from the Australian Academy of Health and Medical Sciences.
Day-to-day palliative care in the community is mainly delivered by an “invisible network” of extended family members, friends and neighbours, Flinders University research shows.
Flinders University researchers will share in grants worth more than $7.6 million from the National Health and Medical Research Council.
A drug which for decades has been widely used to treat pain related to cancer has no net clinical benefit.